Sales & Marketing

"The customer is always right" — a commitment to omnichannel marketing is a commitment to serving the customer. David Laros of Beghou Consulting offers up this tersely written playbook on the topic.

The Anglo-Swedish drugmaker on Monday agreed to pay $26 per CinCor share in cash, or $1.3 billion in total, a premium of nearly 121% to the U.S.-based company's closing price on Friday.

Fran Pollaro chats with with Indegene's Timothy Moore, Senior Vice President, Emerging Biotech and Key Accounts and Jack Mycka, Vice President, Enterprise Medical Solutions and Emerging Biotech.

Using market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.

Angie Lindsey, vice president of marketing, Fresenius Kabi USA shares 2023 strategies for talent management strategies in life sciences, specifically as it relates to sales and marketing.

Pratap Khedkar, CEO of ZS, a management consulting and technology firm focused on transforming global healthcare, shares his perspective on what 2023 holds for the sales and marketing vertical.

Marchesini will serve as Senior Vice President to help life sciences companies improve the effectiveness and efficiency of their commercial processes and go-to-market approach.

Katya Petrova will be responsible for providing JUICE clients with direction and oversight from inception through execution.

Amgen spending big to dive deeper into rare disease treatments through deal for drugmaker Horizon Therapeutics.

Inc. 2022 Best in Business Award marks health-focused TogoRun's second year as an independent, woman-owned agency.

Built on Algorand, and in partnership with the Government of Maharashtra in India, NFT technology will be used for storing personal health data for the first time.

Brand Institute, naming agency, shares insights on emerging clinical trial naming trends.

The move bolsters Evoke’s digital innovation and omnichannel offering.

Whether pharma or FDA, healthcare outreach more visible than ever.

Over half of life sciences companies are not fully optimizing HCP engagement, according to the study.

Tech company Evermed provides modular content hubs that power personalized video content delivery for life science companies and HCPs.

The initiative taps global social influencers and shares resources, so young men can better understand the benefits of therapy.

The transaction allows TherapeuticsMD to recapitalize and transform into a pharmaceutical royalty company while giving Mayne Pharma exclusive U.S. commercialization rights for their products.

CVS is testing a system that allows pharmacists to process prescriptions remotely to help address pharmacist shortage.

Roku's Chris Schneider discusses how pharmaceutical marketers are still missing a huge population: the cord cutters.

Pfizer CEO Albert Bourla, Ph.D., is in trouble for "misleading" and "overly promotional" claims he made during a BBC interview late last year about their COVID-19 vaccine for younger kids, which was not approved at the time.

With biopharma sales and marketing changing faster than ever, it’s become crucial for brands to stay relevant with each new product launch. Christopher Price shares his point of view through the lens of 20 years of experience in the space.

Building on Morgan Health’s accountable care strategy, Dr. Pegus will help inform the team’s renewed focus on population-based health initiatives, including investing in and scaling promising new care delivery models designed to improve health outcomes, particularly among diverse populations.

80% of Rx Patients Currently See Providers with Access to POC Media.

In episode 122, Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits into the future of pharmaceutical marketing.